Chronic GVHD after mismatch unrelated donor stem cell transplantation (9/10) may be associated with PIRCHE (predicted indirectly recognizable HLA epitopes) calculated from six loci HLA

被引：0
|
作者：
Grabowska, M. [1 ]
Moskalik-Kierat, D. [1 ]
Brzoza, M. [1 ]
Wasilewska, A. [1 ]
Rusicka-Krzewska, P. [1 ]
Machowicz, R. [1 ]
Kacprzyk, P. [1 ]
Chmielewska, L. [1 ]
Bilinski, J. [1 ]
Boguradzki, P. [1 ]
Karakulska-Prystupiuk, E. [1 ]
Jedrzejczak, W. W. [1 ]
Tomaszewska, A. [1 ]
Basak, G. W. [1 ]
机构：
[1] Med Univ Warsaw, Univ Clin Ctr, Warsaw, Poland
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P535
引用
收藏
页码：389 / 390
页数：2
相关论文
共 50 条
  • [31] HLA-DPA1 mismatch is associated with decreased overall survival following unrelated donor haematopoietic stem cell transplantation
    Olsson, R.
    Remberger, M.
    Ringden, O.
    Schaffer, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S300 - S300
  • [32] HLA mismatch and clinical outcome after unrelated donor (URD) non-myeloablative hematopoietic stem cell transplantation (NST)
    Ho, VT
    Kim, HT
    Windawi, S
    Liney, D
    Milford, E
    Cutler, C
    Lee, SJ
    Soiffer, RJ
    Antin, JH
    Alyea, EP
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 14 - 15
  • [33] HLA-C mismatch in unrelated and family donor haematopoietic stem cell transplantation for haematological malignancies in children is risk factor for severe acute GvHD
    Enczmann, J
    Meisel, R
    Ogrzewalla, K
    Koegler, G
    Laws, HJ
    Kramm, C
    Bernbeck, B
    Troeger, A
    Wernet, P
    Goebel, U
    Dilloo, D
    BONE MARROW TRANSPLANTATION, 2006, 37 : S90 - S91
  • [34] PREDICTED INDIRECTLY RECOGNIZABLE HLA EPITOPES CORRELATE WITH CHRONIC GRAFT-VERSUS-HOST-DISEASE AND RELAPSE-RELATED MORTALITY IN PEDIATRIC PATIENTS AFTER CORD BLOOD TRANSPLANTATION
    Thus, Kirsten A.
    Kesmir, Can
    Borst, Eric
    de Weger, Roel A.
    Boelens, Jaap Jan
    Spierings, Eric
    HUMAN IMMUNOLOGY, 2013, 74 : 39 - 39
  • [35] HLA-Mismatch Is Associated with Worse Outcomes after Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation: A Cibmtr Analysis
    Pidala, Joseph
    Lee, Stephanie J.
    Spellman, Stephen R.
    Wang, Hailin
    Ahn, Kwang Woo
    Aljurf, Mahmoud D.
    Askar, Medhat
    Dehn, Jason
    Vina, Marcelo A. Fernandez
    Gratwohl, Alois
    Gupta, Vikas
    Hanna, Rabi
    Hurley, Carolyn K.
    Inamoto, Yoshihiro
    Kassim, Adetola A.
    Nishihori, Taiga
    Oudshoorn, Machteld
    Petersdorf, Effie W.
    Prasad, Vinod K.
    Saber, Wael
    Schultz, Kirk R.
    Wood, William A.
    Storek, Jan
    Woolfrey, Ann E.
    Anasetti, Claudio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S25 - S26
  • [36] Predicted indirectly recognizable HLA epitopes correlate with chronic graft-versus-host disease and relapse-related mortality in paediatric patients after cord blood transplantation
    Thus, K. A.
    Kesmir, C.
    Borst, E.
    de Weger, R. A.
    Boelens, J. J.
    Spierings, E.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S87 - S88
  • [37] PREDICTED INDIRECTLY RECOGNIZABLE HLA EPITOPES CORRELATE WITH CHRONIC GRAFT-VERSUS-HOST-DISEASE AND RELAPSE-RELATED MORTALITY IN PAEDIATRIC PATIENTS AFTER CORD BLOOD TRANSPLANTATION
    Thus, Kirsten A.
    Kesmir, Can
    Borst, Eric
    de Weger, Roel A.
    Boelens, Jaap J.
    Spierings, Eric
    TISSUE ANTIGENS, 2013, 81 (05): : 295 - 296
  • [38] Tacrolimus/Sirolimus (T/S)-Based GvHD Prophylaxis Does Not Overcome Poor Outcome of HLA Mismatch after Unrelated Donor (URD) Peripheral Blood Stem Cell Transplantation
    Al Malki, Monzr M.
    Gendzekhadze, Ketevan
    Karanes, Chatchada
    Dagis, Andy
    Palmer, Joycelynne
    Anh Pham
    Parker, Pablo
    Senitzer, David
    Nademanee, Auayporn
    Forman, Stephen J.
    Nakamura, Ryotaro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S419 - S419
  • [39] Post-Transplantation High Dose Cyclophosphamide As Gvhd Prophylaxis in 9/10 HLA-Matched Unrelated Donors Hematopoietic Stem Cell Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Chen, Julianne
    Rondon, Gabriela
    Hammerstrom, Aimee E.
    Alousi, Amin M.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    Ahmed, Sairah
    Popat, Uday R.
    Hosing, Chitra M.
    Khouri, Issa F.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Ciurea, Stefan O.
    BLOOD, 2015, 126 (23)
  • [40] Is the use of 9/10 HLA unrelated donors still acceptable in allogeneic haematopoietic stem cell transplantation for haematological malignancies? Comparison with transplants from 10/10 HLA unrelated donors and siblings
    Michallet, M.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Labussiere, H.
    Tedone, N.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Nicolini, F.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S297 - S298
12345